Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The longitudinal use of SaNDVis: visual social network analytics in the enterprise.

Perer A, Guy I, Uziel E, Ronen I, Jacovi M.

IEEE Trans Vis Comput Graph. 2013 Jul;19(7):1095-108. doi: 10.1109/TVCG.2012.322.

PMID:
23661007
2.

Fetal safety of macrolides.

Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, Levy A.

Antimicrob Agents Chemother. 2013 Jul;57(7):3307-11. doi: 10.1128/AAC.01691-12. Epub 2013 May 6.

3.

Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.

Daniel S, Matok I, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A.

J Rheumatol. 2012 Nov;39(11):2163-9. doi: 10.3899/jrheum.120453. Epub 2012 Sep 15.

PMID:
22984274
4.

The safety of fetal exposure to proton-pump inhibitors during pregnancy.

Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R.

Dig Dis Sci. 2012 Mar;57(3):699-705. doi: 10.1007/s10620-011-1940-3. Epub 2011 Oct 30.

PMID:
22038541
5.

Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.

Levy A, Matok I, Gorodischer R, Sherf M, Wiznitzer A, Uziel E, Koren G.

J Clin Pharmacol. 2012 Jan;52(1):78-83. doi: 10.1177/0091270010390806. Epub 2011 Feb 22.

PMID:
21343345
6.

The safety of H(2)-blockers use during pregnancy.

Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Uziel E, Levy A.

J Clin Pharmacol. 2010 Jan;50(1):81-7. doi: 10.1177/0091270009350483. Epub 2009 Sep 29.

PMID:
19789371
7.

[Crisis intervention--the summary of a unique interventional program for medical students].

Perry Z, Busiba Z, Uziel E, Meiri G.

Harefuah. 2009 Feb;148(2):87-92, 139-40. Hebrew.

PMID:
19627035

Supplemental Content

Support Center